BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8381162)

  • 1. The potential for oligodendrocyte proliferation during demyelinating disease.
    Prayoonwiwat N; Rodriguez M
    J Neuropathol Exp Neurol; 1993 Jan; 52(1):55-63. PubMed ID: 8381162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulins stimulate central nervous system remyelination: electron microscopic and morphometric analysis of proliferating cells.
    Rodriguez M
    Lab Invest; 1991 Mar; 64(3):358-70. PubMed ID: 2002654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice.
    Godfraind C; Friedrich VL; Holmes KV; Dubois-Dalcq M
    J Cell Biol; 1989 Nov; 109(5):2405-16. PubMed ID: 2553746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-induced demyelination in mice: "dying back" of oligodendrocytes.
    Rodriguez M
    Mayo Clin Proc; 1985 Jul; 60(7):433-8. PubMed ID: 4040195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis.
    Yamada M; Zurbriggen A; Fujinami RS
    J Exp Med; 1990 Jun; 171(6):1893-907. PubMed ID: 1693653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remyelination by oligodendrocytes stimulated by antiserum to spinal cord.
    Rodriguez M; Lennon VA; Benveniste EN; Merrill JE
    J Neuropathol Exp Neurol; 1987 Jan; 46(1):84-95. PubMed ID: 2432195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease.
    Aubert C; Chamorro M; Brahic M
    Microb Pathog; 1987 Nov; 3(5):319-26. PubMed ID: 2849023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited remyelination in Theiler's murine encephalomyelitis due to insufficient oligodendroglial differentiation of nerve/glial antigen 2 (NG2)-positive putative oligodendroglial progenitor cells.
    Ulrich R; Seeliger F; Kreutzer M; Germann PG; Baumgärtner W
    Neuropathol Appl Neurobiol; 2008 Dec; 34(6):603-20. PubMed ID: 18466224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of proteolipid protein and P0 transcripts in mice infected with Theiler's virus.
    Ozden S; Aubert C; Bureau JF; Gonzalez-Dunia D; Brahic M
    Microb Pathog; 1993 Feb; 14(2):123-31. PubMed ID: 7684806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis.
    Yao DL; Liu X; Hudson LD; Webster HD
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6190-4. PubMed ID: 7541143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins.
    Miller SD; Clatch RJ; Pevear DC; Trotter JL; Lipton HL
    J Immunol; 1987 Jun; 138(11):3776-84. PubMed ID: 2438327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between viral RNA, myelin-specific mRNAs, and demyelination in central nervous system disease during Theiler's virus infection.
    Yamada M; Zurbriggen A; Fujinami RS
    Am J Pathol; 1990 Dec; 137(6):1467-79. PubMed ID: 2260633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observations on demyelinating lesions induced by Theiler's virus in CBA mice.
    Blakemore WF; Welsh CJ; Tonks P; Nash AA
    Acta Neuropathol; 1988; 76(6):581-9. PubMed ID: 3201921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro analysis of the oligodendrocyte lineage in mice during demyelination and remyelination.
    Armstrong R; Friedrich VL; Holmes KV; Dubois-Dalcq M
    J Cell Biol; 1990 Sep; 111(3):1183-95. PubMed ID: 2167897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical localization of MAG, MBP and P0 protein in acute and relapsing demyelinating lesions of Theiler's virus infection.
    Dal Canto MC; Barbano RL
    J Neuroimmunol; 1985 Dec; 10(2):129-40. PubMed ID: 2415554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolipid protein gene expression in demyelination and remyelination of the central nervous system: a model for multiple sclerosis.
    Rodriguez M; Prayoonwiwat N; Howe C; Sanborn K
    J Neuropathol Exp Neurol; 1994 Mar; 53(2):136-43. PubMed ID: 7509847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulins and complement in demyelination induced in mice by Theiler's virus.
    Rodriguez M; Lucchinetti CF; Clark RJ; Yakash TL; Markowitz H; Lennon VA
    J Immunol; 1988 Feb; 140(3):800-6. PubMed ID: 3339243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remyelination during remission in Theiler's virus infection.
    Dal Canto MC; Barbano RL
    Am J Pathol; 1984 Jul; 116(1):30-45. PubMed ID: 6742106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oligodendroglial reaction to brain stab wounds: an immunohistochemical study.
    Xie D; Schultz RL; Whitter EF
    J Neurocytol; 1995 Jun; 24(6):435-48. PubMed ID: 7595660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent demyelination in chronic central nervous system infection produced by Theiler's murine encephalomyelitis virus.
    Dal Canto MC; Lipton HL
    J Neurol Sci; 1979 Aug; 42(3):391-405. PubMed ID: 512673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.